The results were presented at Charing Cross 2026 by Dr. Andrew Holden during a session on Abdominal Aortic Aneurysm (AAA) disease management
Xeltis receives CE mark for aXess™, its aXess hemodialysis conduit ™, as it moves to commercialization
CE mark awarded for aXess™ at record speed, underpinned by strong EU pivotal trial data























